Liver cirrhosis: modern approaches to diagnosis and treatment


DOI: https://dx.doi.org/10.18565/therapy.2022.6.97-108

Shchyokotova A.P.

Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia
Abstract. The lecture presents the classification, clinical picture and course of liver cirrhosis (LC), which includes not only hepatic syndromes of previous chronic liver damage, but portal hypertension (PH) syndrome is the leading one for diagnosis. For the tactics of treatment of cirrhosis and prognosis, it is necessary to identify the stage of the disease, which characterizes compensation, decompensation, and the terminal state. The stratification of stages is determined by the severity of PH and the presence of complications of the disease in the form of refractory ascites, hepatic encephalopathy, bleeding from varicose esophagogastric veins, infectious manifestations, hepatorenal syndrome, hepatic cardiomyopathy, hepatopulmonary syndrome, dilutional hyponatremia, portal vein thrombosis, hypersplenism, ospeoporosis, sarcopenia, hepatocellular carcinoma. The diagnostic criteria for complications and the tactics of their treatment are characterized. General principles of cirrhosis treatment, assessment of cirrhosis prognosis and indications for liver transplantation are given.

Literature


1. Moon A.M., Singal A.G., Tapper E.B. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020; 18(12): 2650–66. https://dx.doi.org/10.1016/j.cgh.2019.07.060.


2. Ивашкин В.Т., Маевская М.В., Павлов Ч.С. с соавт. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26(4): 71–102. [Ivashkin V.T., Maevskaya M.V., Pavlov Ch.S. et al. Clinical guidelines of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association for the treatment of complications of liver cirrhosis. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26(4): 71–102 (In Russ.)]. EDN: YHTFXB.


3. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей: практическое руководство. Пер. с англ. Под ред. З.Г. Апросиной, Н.А. Мухина. М.: ГЭОТАР-Мед. 2002; 864 с. [Sherlock Sh., Duli J. Diseases of the liver and biliary tract: a practical guide. Translation from English. Ed. by Aprosina Z.G., Mukhin N.A. Moscow: GEOTAR-MED. 2002; 864 pp. (In Russ.)]. ISBN: 5-9231-0174-2.


4. Ивашкин В.Т., Маевская М.В., Жаркова М.С. с соавт. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по диагностике и лечению фиброза и цирроза печени и их осложнений. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021; 31(6): 56–102. [Ivashkin V.T., Maevskaya M.V., Zharkova M.S. et al. Clinical recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on diagnosis and treatment of liver fibrosis, cirrhosis and their complications. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021; 31(6): 56–102 (In Russ.)].https://dx.doi.org/10.22416/13824376-2021-31-6-56-102. EDN: GMKWTQ.


5. Ивашкин В.Т. Болезни печени и желчевыводящих путей. Руководство для врачей. 2-е издание. М.: ИД «М-Вести». 2005; 536 с. [Ivashkin V.T. Diseases of the liver and biliary tract. Guide for doctors. 2nd ed. Moscow: Publishing house «M-Vesti». 2005; 536 pp. (In Russ.)]. ISBN: 5-901598-12-1.


6. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018; 69(2): 406–60. https://dx.doi.org/10.1016/j.jhep.2018.03.024.


7. Marwach D. Complete review of medicine for NBE. 4th edition. New Delhi: CBS (PGMEE). 2018; 940 pp. ISBN-10: -9386827492; ISBN-13: 978-9386827494.


8. Zipprich A., Garcia-Tsao G., Rogowski S. et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012; 32(9): 1407–14. https://dx.doi.org/10.1111/j.1478-3231.2012.02830.x.


9. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018; 69(1): 154–81. https://dx.doi.org/10.1016/j.jhep.2018.03.018.


10. Клинические рекомендации EASL–EASD–EASO по диагностике и лечению неалкогольной жировой болезни печени. Journal of Hepatology. 2016; 64: 1388–1402. Доступ: https://easl.eu/wp-content/uploads/2018/10/2016-NAFLD_RU.pdf (дата обращения – 01.08.2022). [EASL–EASD–EASO clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease. Journal of Hepatology. 2016; 64: 1388–1402. URL: https://easl.eu/wp-content/uploads/2018/10/2016-NAFLD_RU.pdf (date of access – 01.08.2022) (In Russ.)].


11. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015; 63(4): 971–1004. https://dx.doi.org/10.1016/j.jhep.2015.06.030.


12. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017; 67(1): 145–72. https://dx.doi.org/10.1016/j.jhep.2017.03.022.


13. Bloom S., Kemp W. J. Portal hypertension: Pathophysiology, diagnosis and management. Intern Med J. 2015; 45(1): 16–26.https://dx.doi.org/10.1111/imj.12590.


14. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53(3): 397–417. https://dx.doi.org/10.1016/j.hep.2010.05.004.


15. Павлов Ч.С., Дамулин И.В., Ивашкин В.Т. Печеночная энцефалопатия: патогенез, клиника, диагностика, терапия. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26(1): 44–53. [Pavlov Ch.S., Damulin I.V., Ivashkin V.T. Hepatic encephalopathy: pathogenesis, clinical presentation, diagnostics, treatment. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26(1): 44–53 (In Russ.)].https://dx.doi.org/10.22416/1382-43762016-26-1-44-53. EDN: YIYGCZ.


16. Angeli P., Garcia-Tsao G., Nadim M.K., Parikh R.C. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019; 71(4): 811–22.https://dx.doi.org/10.1016/J.JHEP.2019.07.002.


17. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018; 69(1): 182–236. https://dx.doi.org/10.1016/j.jhep.2018.03.019.


18. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019; 70(1): 172–93. https://dx.doi.org/10.1016/j.jhep.2018.06.024.


19. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016; 64(2): 433–85. https://dx.doi.org/10.1016/j.jhep.2015.10.006.


About the Autors


Alevtina P. Shchyokotova, Dr. med. habil., professor of the Department of faculty therapy No. 2, occupational pathology and clinical laboratory diagnostics, Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia. Address: 614990, Perm, 26 Petropavlovskaya Str. Е-mail: al_shchekotova@mail.ru


Similar Articles


Бионика Медиа